Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma
{{output}}
Anthracyclines have a central role in the management of non-Hodgkin's lymphoma (NHL). The cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) treatment regimen has been the standard of care for more than 20 years. Further improvements have been m... ...
